A Systematic Review of AI-Enabled Antimicrobial Stewardship and Therapeutics in Critical Care Medicine
Journal of Pharma Insights and Research · 05.04.2026 · 4 (2) · 320-331
DOI: 10.69613/c7006n84 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Pharma Insights and Research, online erschienen am 05.04.2026. Verfasst von Zunera Fatima und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intensive care units act as epicenters for the selection and dissemination of multidrug-resistant pathogens. High antimicrobial pressure, invasive interventions, and critically ill cohorts drive the selection of resistant strains. A systematic analysis of evidence from January 2020 to December 2025 showed that Gram-negative ESKAPE pathogens, notably carbapenem-resistant Enterobacterales and Acinetobacter baumannii, dominate critical care infections. Mechanistic pathways involve beta-lactamase production, porin mutations such as OprD down-regulation in Pseudomonas aeruginosa, and active efflux systems like the AcrAB-TolC pump. Rapid molecular diagnostic platforms, including polymerase chain reaction assays and matrix-assisted laser desorption ionization-time of flight mass spectrometry, significantly accelerate pathogen identification compared to standard cultures. When integrated with artificial intelligence and machine learning models, clinical decision support tools optimize antibiotic prescriptions, reducing inappropriate administration by twenty to thirty-five percent as measured by days of therapy per one thousand patient-days and strict adherence to institutional antibiograms. Novel drugs, specifically cefiderocol, novel beta-lactam/beta-lactamase inhibitor combinations, and experimental options such as bacteriophages and CRISPR-Cas gene-editing therapies, offer optimistic alternatives against pan-drug-resistant isolates. Effective containment of critical care antimicrobial resistance requires a structured paradigm transition combining real-time genomic surveillance, machine learning risk stratification, and targeted drugs to improve clinical recovery rates while preserving last-resort antimicrobial classes
Zitieren
APA
Fatima, Z., & Biyabani, S. A. U. (2026). A Systematic Review of AI-Enabled Antimicrobial Stewardship and Therapeutics in Critical Care Medicine. Journal of Pharma Insights and Research, 4(2), 320-331. https://doi.org/10.69613/c7006n84
Vancouver
Fatima Z, Biyabani SAU. A Systematic Review of AI-Enabled Antimicrobial Stewardship and Therapeutics in Critical Care Medicine. Journal of Pharma Insights and Research. 2026;4(2):320-331. doi:10.69613/c7006n84
BibTeX
@article{Fatima2026,
author = {Fatima, Zunera and Biyabani, Syed Afzal Uddin},
title = {A Systematic Review of AI-Enabled Antimicrobial Stewardship and Therapeutics in Critical Care Medicine},
journal = {Journal of Pharma Insights and Research},
year = {2026},
volume = {4},
number = {2},
pages = {320--331},
doi = {10.69613/c7006n84}
}
EUVIMED